Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Trends in Parasitology|December 17, 2024
Do tissue-dwelling trypanosomes sustain transmission populations?Stephen D Larcombe, Jane C Munday, Richard McCulloch
Frontiers in Pharmacology|March 28, 2015
Transport proteins determine drug sensitivity and resistance in a protozoan parasite, Trypanosoma bruceiJane C Munday, Luca Settimo, Harry P de Koning
Molecular and Biochemical Parasitology|January 27, 2018
Trypanosoma brucei bloodstream forms express highly specific and separate transporters for adenine and hypoxanthine; evidence for a new protozoan purine transporter family?Gustavo D Campagnaro, Khalid J Alzahrani, Jane C Munday, et al.
Molecular and Biochemical Parasitology|October 2, 2010
Oligopeptidase B deficient mutants of Leishmania majorJane C Munday, Karen McLuskey, Elaine Brown, et al.
International Journal for Parasitology. Drugs and Drug Resistance|June 5, 2015
Chimerization at the AQP2-AQP3 locus is the genetic basis of melarsoprol-pentamidine cross-resistance in clinical Trypanosoma brucei gambiense isolatesFabrice E Graf, Nicola Baker, Jane C Munday, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2012
Aquaglyceroporin 2 controls susceptibility to melarsoprol and pentamidine in African trypanosomesNicola Baker, Lucy Glover, Jane C Munday, et al.
Plos One|March 19, 2013
Pyrimidine biosynthesis is not an essential function for Trypanosoma brucei bloodstream formsJuma A M Ali, Daniel N A Tagoe, Jane C Munday, et al.
Plos Neglected Tropical Diseases|August 13, 2016
Reduced Mitochondrial Membrane Potential Is a Late Adaptation of Trypanosoma brucei brucei to Isometamidium Preceded by Mutations in the γ Subunit of the F1Fo-ATPaseAnthonius A Eze, Matthew K Gould, Jane C Munday, et al.
Journal of Medicinal Chemistry|February 15, 2019
Novel Minor Groove Binders Cure Animal African Trypanosomiasis in an in Vivo Mouse ModelFederica Giordani, Abedawn I Khalaf, Kirsten Gillingwater, et al.
Antimicrobial Agents and Chemotherapy|August 15, 2018
Cyclic Nucleotide-Specific Phosphodiesterases as Potential Drug Targets for Anti-Leishmania TherapyVictor Sebastián-Pérez, Sarah Hendrickx, Jane C Munday, et al.
Pageof 3